Yazar "Ozdemir, Ayse" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Perspectives of Usak University faculty of medicine and dentistry students to biochemistry course
    (2019) Ozdemir, Ayse
    Aim: In this study, we aimed to share our experiences about patients with miscellaneous non-specific malign stromal tumors of testis. We report the demographic and clinical characteristics and the long-term results in patients with non-specific malign stromal tumors of testis.Material and Methods: 234 patients with testicular cancer between June 1994 and January 2019 have been evaluated retrospectively. Eleven patients (Dedifferentiated liposarcoma, Diffuse large B-cell lymphoma, Embryonal rhabdomyosarcoma, Adenocarcinoma of the epididymis, Ewing’s sarcoma of the testis, Testicular leiomyosarcoma, Well-differentiated liposarcoma, Paratesticular high grade sarcoma and Paratesticular malignant mesothelioma) whose data were reached, are taken into the study. Patients’ age, scrotal localization of symptoms, clinical examination findings, serum tumor marker levels, pathology results and follow-up period were recorded. Results:The mean age at diagnosis was 43.7 years (range, 18 to 79). 54.5% of the lesions were localized to the right hemiscrotal area and of 45.4% to the left hemiscrotal area. None of patients had a history of unilateral undescended testis in medical history or testicular cancer in familial history. Serum tumor markers were normal in all patients. The mean scrotal mass lesion at diagnosis was 59.9 mm3 (range, 33 to 138 mm3). 3 or 4 cyles of chemotherapy protocols were administered in necessary cases. Mean follow-up period was 80.6 months (range, 12 to 297 months). Tumor recurrence was occured in only two patients (Dedifferentiated liposarcoma and Adenocarcinoma of the epididymis) during the follow-up.Conclusion: Miscellaneous non-specific malign stromal tumors of the testis should be kept in mind especially in middle age group patients presented with malign scrotal lesions. Surgical treatment should be aggressive and additional specific treatment according to pathology result should be planned without delay. Follow-up protocols are recommended to be tumor specific.
  • Küçük Resim
    Öğe
    Use of complementary and alternative medicine (CAM) methods by cancer patients admitted to oncology polyclinic and evaluation of these methods for life quality
    (2019) Ozdemir, Ayse
    Aim: In the present study, our aim is to assess cancer patients receiving treatment in Outpatient Chemotherapy Unit in terms of demographic characteristics and life quality and to investigate the use of CAM methods and the factors affecting the use of such methods. Material and Methods: The sample of this descriptive study consists of 100 cancer patients treated in Outpatient Chemotherapy Unit. A questionnaire form was used in the study as a data collection tool. The questionnaire form prepared following the approval of local ethical committee was applied to the patients admitted to oncology unit for outpatient chemotherapy. Results: 56% of patients were males and 44% of them were females. They were aged minimum 40 and maximum 89. 39% of patients had breast cancer, 22% of them had colorectal cancer, 20% of them had lung cancer, 15% of them had prostate cancer, %2 of them had uterine (endometrium) cancer, and 2% of them had bladder cancer. 23 out of 100 patients in the sample used alternative treatment methods. 20 of them preferred herbal therapy while 3 of them used acupuncture. A great majority of patients resorting to alternative treatment methods were housewives and had lung, breast or colorectal cancer. It was observed that less patients with urogenital cancer resorted to CAM methods. Conclusion: As a result of this study, it was detected that 23% of cancer patients used one of the CAM methods, the most common one being the herbal therapy. Physicians and other healthcare professionals must be knowledgeable about the effects and side effects of these treatment methods and must warn the cancer patients about their probable complications. Moreover, an interesting result is that, in Turkey, cancer patients are not informed on their diagnosis by relatives and healthcare professionals